作者: Robin Polt , Edward J Bilsky , Richard D Egleton , ARIZONA UNIV TUCSON DEPT OF CHEMISTRY
DOI:
关键词:
摘要: Abstract : The use of endogenous neuropeptides such as enkephalins and endorphins drugs has remained an elusive goal since the 1970's. principle reason for this is that peptides generally do not cross blood-brain barrier, are quickly degraded in blood stream prior to delivery opiate receptors brain. Animal research with glycosylated (dynorphins) indicates potent analgesia possible after intravenous or sub-cutaneous injection. Glycopeptides derived from delta-selective opioid agonists have 2-3X potency morphine, lack many side effects associated muagonists morphine. Morphine still used on battlefield combat casualty care, it anticipated further development glycopeptide analgesics will result superior greatly reduced effects. Recent developments area reported.